These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12088078)

  • 1. Menkes gene study in the Chinese population.
    Mak BS; Chi CS; Tsai CR
    J Child Neurol; 2002 Apr; 17(4):250-2. PubMed ID: 12088078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene symbol: ATP7A. Disease: Menkes disease.
    Tumer Z; Horn N; Tonnesen T; Christodoulou J; Clarke JT; Sarkar B
    Hum Genet; 2004 May; 114(6):606. PubMed ID: 15176369
    [No Abstract]   [Full Text] [Related]  

  • 3. Variable clinical expression of an identical mutation in the ATP7A gene for Menkes disease/occipital horn syndrome in three affected males in a single family.
    Borm B; Møller LB; Hausser I; Emeis M; Baerlocher K; Horn N; Rossi R
    J Pediatr; 2004 Jul; 145(1):119-21. PubMed ID: 15238919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation of L718X in the ATP7A gene in a Japanese patient with classical Menkes disease, and four novel polymorphisms in the Japanese population.
    Ogawa A; Yamamoto S; Kanazawa M; Ogawa E; Takayanagi M; Hasegawa S; Kohno Y
    J Hum Genet; 2000; 45(5):315-7. PubMed ID: 11043517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel deletion mutation of ATP7A gene in a Chinese family with Menkes disease.
    Zhang LP; Lü JL; Wang XH; Zou LP
    Chin Med J (Engl); 2008 Jan; 121(2):175-7. PubMed ID: 18272047
    [No Abstract]   [Full Text] [Related]  

  • 6. A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase.
    Kim BE; Smith K; Petris MJ
    J Med Genet; 2003 Apr; 40(4):290-5. PubMed ID: 12676902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical manifestations of Menkes disease vary according to patient's genotype and the initiation time of treatment with copper-histidine injections].
    Yagi M; Kusunoki N; Lee T; Awano H; Kodama H; Takeshima Y; Iijima K
    No To Hattatsu; 2014 May; 46(3):227-8. PubMed ID: 24902345
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
    Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
    Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Menkes' disease and brain dysfunction].
    Aoki T; Yamaguchi Y; Omura I; Watanabe A; Shimizu N
    No To Shinkei; 2001 May; 53(5):427-35. PubMed ID: 11424353
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening of 383 unrelated patients affected with Menkes disease and finding of 57 gross deletions in ATP7A.
    Tümer Z; Birk Møller L; Horn N
    Hum Mutat; 2003 Dec; 22(6):457-64. PubMed ID: 14635105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.
    Paulsen M; Lund C; Akram Z; Winther JR; Horn N; Møller LB
    Am J Hum Genet; 2006 Aug; 79(2):214-29. PubMed ID: 16826513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel two-nucleotide deletion in the ATP7A gene associated with delayed infantile onset of Menkes disease.
    Wada T; Haddad MR; Yi L; Murakami T; Sasaki A; Shimbo H; Kodama H; Osaka H; Kaler SG
    Pediatr Neurol; 2014 Apr; 50(4):417-20. PubMed ID: 24630286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Ile/Val polymorphism at codon 1464 of the ATP7A gene.
    Ogawa A; Yamamoto S; Takayanagi M; Kogo T; Kanazawa M; Kohno Y
    J Hum Genet; 1999; 44(6):423-4. PubMed ID: 10570920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase.
    Vulpe C; Levinson B; Whitney S; Packman S; Gitschier J
    Nat Genet; 1993 Jan; 3(1):7-13. PubMed ID: 8490659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menkes disease mutations and response to early copper histidine treatment.
    Kaler SG
    Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical utility gene card for: Menkes disease.
    Tümer Z; Klomp L
    Eur J Hum Genet; 2011 Oct; 19(10):. PubMed ID: 21487442
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the exon structure of the Menkes disease gene using vectorette PCR.
    Tümer Z; Vural B; Tønnesen T; Chelly J; Monaco AP; Horn N
    Genomics; 1995 Apr; 26(3):437-42. PubMed ID: 7607665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.
    Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP
    Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset treatment in Menkes disease: is there a correlation between genotype and response to therapy?
    Olivares JL; Bueno I; Gallati S; Ramos FJ
    Clin Genet; 2006 Apr; 69(4):363-6. PubMed ID: 16630173
    [No Abstract]   [Full Text] [Related]  

  • 20. Translational read-through of a nonsense mutation in ATP7A impacts treatment outcome in Menkes disease.
    Kaler SG; Tang J; Donsante A; Kaneski CR
    Ann Neurol; 2009 Jan; 65(1):108-13. PubMed ID: 19194885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.